AI assistant
Life360, Inc. — Director's Dealing 2020
Mar 23, 2020
30724_rns_2020-03-23_72148ead-1d9f-49be-abc5-f3b015b0bba0.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity: Life360, Inc.
ARBN: 629 412 942
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | James Synge |
|---|---|
| Date of last notice | 16/03/2020 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect Interest |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | Stynge Pty Limited ATF Sandy Bay Trust |
| Date of change | 19/03/2020 & 20/03/2020 |
| No. of securities held prior to change | 485,034 Shares (equivalent to 1,455,102CDIs)1,563 RSUs64,379 Shares (equivalent to 193,137 CDIs)held by ICCA Labs, LLC70,000 CDIs held by Stynge Pty Ltd ATFSandyBayTrust |
| Class | CDIs |
| Number acquired | 10,598 CDIs |
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | 19/03/2020 – 10,000 CDIs @ $1.70 per CDI20/03/2020 – 598 CDIs @ $1.65 per CDI |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | 485,034 Shares (equivalent to 1,455,102CDIs)1,563 RSUs64,379 Shares (equivalent to 193,137 CDIs)held by ICCA Labs, LLC80,598 CDIs held by Stynge Pty Ltd ATFSandy Bay Trust |
|---|---|
| Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back | On-market purchase of CDIs |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Part 2 –Note: In thebe disclosed | Change of director’s interests incase of a company, interests which come within p | Change of director’s interests incase of a company, interests which come within p | contractsaragraph (ii) of the definition of “notifiable intere | st of a director” should |
|---|---|---|---|---|
| in this part. | ||||
| Detail o | f contract | N/ | A | |
| Nature | f interest | N | A | |
| Name of registered holder(if issued securities) | N/A | |||
| Date of change | N/A | |||
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | N/A | |||
| Interest acquired | N/A | |||
| Interest disposed | N/A | |||
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | N/A | |||
| Interest after change | N/A |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | No. |
| If so, was prior written clearance provided to allow the tradeto proceed during this period? | N/A |
| If prior written clearance was provided, on what date was thisprovided? | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3